{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:12:35Z","timestamp":1789960355390,"version":"4.0.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1212\/wnl.46.5.1337","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:19:55Z","timestamp":1336915195000},"page":"1337-1337","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Late\u2010onset muscle weakness in partial phosphofructokinase deficiency"],"prefix":"10.1212","volume":"46","author":[{"given":"Kumaraswamy","family":"Sivakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavo","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinos C.","family":"Dalakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"DiMauro S Tsujino S. Nonlysosomal glycogenoses. In: Engel AG Franzini-Armstrong C eds. Myology. New York: McGraw Hill 1994:1384\u20131398."},{"key":"e_1_3_1_3_2","first-page":"2","volume":"120","year":"1969","unstructured":"Serratrice G, Monges A, Raux H, Aquaron R, Gambarelli R. Forme myopathique du deficit en phosphofructikinase. Rev Neurol (Paris) 1969;120:270\u2013277.","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.1.1"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.1.9"},{"key":"e_1_3_1_6_2","first-page":"1","volume":"44","year":"1994","unstructured":"Argov Z, Barash V, Soffer D, Sherman D, Raben N. Adult-onset muscular weakness in phosphofructokinase deficiency due to exon 5\/intron 5 junction point mutation: A unique disorder or the natural course of this glycolytic disorder? Neurology 1994;44:1097\u20131100.","journal-title":"Adult-onset muscular weakness in phosphofructokinase deficiency due to exon 5\/intron 5 junction point mutation: A unique disorder or the natural course of this glycolytic disorder? Neurology"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118008"},{"key":"e_1_3_1_8_2","first-page":"4","volume":"268","year":"1993","unstructured":"Raben N, Sherman JB, Miller F, et al. A 5\u2032 splice junction mutation leading to exon deletion in an Ashkenazi Jewish family with phosphofructokinase deficiency (Tarui's Disease). J Biol Chem 1993;268:4963\u20134967.","journal-title":"J Biol Chem"},{"key":"e_1_3_1_9_2","first-page":"3","volume":"55","year":"1994","unstructured":"Sherman JB, Raben N, Nicastri C, et al. Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis-VII and their population frequency. Am J Hum Genetic 1994;55:305\u2013313.","journal-title":"Am J Hum Genetic"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)40186-5"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130102"},{"key":"e_1_3_1_12_2","first-page":"6","volume":"33","year":"1976","unstructured":"Chui LA, Munsat TL. Dominant inheritance of McArdle syndrome. Arch Neurol 1976;33:636\u2013641.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.1.1"},{"key":"e_1_3_1_14_2","unstructured":"Rowland LP DiMauro S Layzer RB. Phosphofructokinase deficiency. In: Engel AG Franzini-Armstrong C eds. Myology. New York McGraw Hill 1986:1603\u20131617."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116550"},{"key":"e_1_3_1_16_2","first-page":"9","volume":"50","year":"1992","unstructured":"Moraes CT, Ricci E, Bonilla E, DiMauro S, Schon EA. The mitochondrial tRNA1eu(UUR) mutation in MELAS: genetic, biochemical, and morphological correlation in skeletal muscle. Am J Hum Genet 1992;50:934\u2013949.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_17_2","first-page":"2","volume":"4","year":"1993","unstructured":"Moraes CT, Ciacci F, Bonilla E, Ionasescu V, Schon EA, Di-Mauro S. A mitochondrial tRNA anticodon swap associated with muscle diseases. Nature Genet 1993;4:284\u2013287.","journal-title":"Nature Genet"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","unstructured":"Lewis SF Vora S Haller RG. Abnormal oxidative metabolism and 0 2 transport in muscle phosphofructokinase deficiency. J Ap pl Physiol 199 1; 70:3 9 1\u2013398.","DOI":"10.1152\/jappl.1991.70.1.391"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Haller RG Lewis SF. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 1991; 324:364\u2013369.","DOI":"10.1056\/NEJM199102073240603"},{"key":"e_1_3_1_20_2","first-page":"8","volume":"36","year":"1994","unstructured":"Bank W, Chance B. An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry. Ann Neurol 1994;36:830\u2013837.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113033"},{"key":"e_1_3_1_22_2","first-page":"9","volume":"8","year":"1982","unstructured":"Vora S, Durham S, deMartinville B, et al. Assignment of the human gene for muscle-type phosphofructokinase (PFKM) to chromosome 1 (region-q32) using somatic cell hybrids and monoclonal anti-M antibody. Somatic Cell Genet 1982;8:95\u2013104.","journal-title":"Somatic Cell Genet"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320540104"},{"key":"e_1_3_1_24_2","first-page":"4","volume":"202","year":"1994","unstructured":"Hamaguchi T, Nakajima H, Noguchi T, et al. A new variant of muscle phosphofructokinase deficiency in a Japanese case with abnormal RNA splicing. Biochem Biophys Res Commun 1994;202:444\u2013449.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.46.5.1337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:06:54Z","timestamp":1711548414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.46.5.1337"}},"subtitle":["A unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5\/intron 5 junction point mutation"],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["10.1212\/WNL.46.5.1337"],"URL":"https:\/\/doi.org\/10.1212\/wnl.46.5.1337","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}